Company:  AXOGEN, INC. (AXGN)
Form Type:  8-K
Filing Date:  7/11/2013 
CIK:  0000805928 
Address:  13859 PROGRESS BLVD
SUITE 100 
City, State, Zip:  ALACHUA, Florida 32615 
Telephone:  (386) 462-6817 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$3.44   		Change: 
0.09 (2.69%)  
Trade Time: 
Jan 30   		Market Cap: 
$67.04M
Description of Business
We are a leading medical technology company dedicated to advancing the science and commercialization of peripheral nerve repair solutions. Peripheral nerves provide the pathways for both motor and sensory signals throughout the body and their damage can result in the loss of muscle function and/or feeling. Nerves can be damaged in a number of ways. When a nerve is cut due to a traumatic injury or surgery, functionality of the nerve may be compromised, causing the nerve to no longer carry the signals to and from the brain to the muscles and skin. This type of injury generally requires a surgical repair. The traditional gold standard has been to either suture the nerve ends together directly without tension or to bridge the gap between the nerve ends with a less important nerve surgically removed from elsewhere in the patient�s own body referred to as nerve autograft.
Register for EDGAR Pro and access this filing in:     
  FORM 8-K
    SECTION 2 FINANCIAL INFORMATION
      Item 2.02 Results of Operations and Financial Condition
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      Item 9.01. Financial Statements and Exhibits
    SIGNATURE
    EXHIBIT INDEX
  EXHIBIT 99.1
    BALANCE SHEET
    INCOME STATEMENT
    CASH FLOW
BROKERAGE PARTNERS
© 1995-2015 EDGAR Online, Inc. All rights reserved • NASDAQ: EDGR • Solutions for Corporations • Terms of Use • Privacy Statement